source
- New FDA Oncology Center chief Angelo de Claro pledges AI integration and trial expansionAngelo de Claro, M.D., has taken over as the permanent head of the FDA’s Oncology Center of Excellence after serving as acting director since late 2025. In his first interview, he said the agency w…
- Sandoz to invest $1 billion in European biosimilar hub, targeting 100 biosimilars by 2040Sandoz announced at its investor day that it will spend roughly $1 billion to build a fully integrated European biosimilar hub as part of a plan to bring more than 100 biosimilars to market by 2040…